These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9869892)

  • 1. The effect of cyclosporine on regulators of fibrinolysis in plasma from renal allograft recipients.
    Elhasade AS; Perkowska A; Paczek L; Rowiński W; Soluch L; Szmidt J; Gałazka Z; Gaciong Z
    Ann Transplant; 1998; 3(1):13-8. PubMed ID: 9869892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of chronic allograft rejection on plasma regulators of fibrinolysis.
    Perkowska A; Elhasade A; Durlik M; Placha G; Gałazka Z; Lao M; Gaciong Z
    Ann Transplant; 2002; 7(1):44-51. PubMed ID: 12221903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma fibrinolytic capacity in renal transplant recipients: effect of steroid-free immunosuppression therapy.
    Sartori MT; Rigotti P; Marchini F; Spiezia L; Baldan N; Furian L; Varvarikis C; Girolami A
    Transplantation; 2003 Apr; 75(7):994-8. PubMed ID: 12698086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients.
    van den Dorpel MA; Levi M; IJzermans JN; ten Cate JW; Weimar W
    Transplant Proc; 1999; 31(1-2):329. PubMed ID: 10083130
    [No Abstract]   [Full Text] [Related]  

  • 5. Improved fibrinolytic capacity after withdrawal of steroid immunosuppression in renal transplant recipients.
    Sartori MT; Patrassi GM; Rigotti P; Marchini F; Fioretti M; Spiezia L; Girolami A
    Transplantation; 2000 May; 69(10):2116-21. PubMed ID: 10852608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The coagulo-lytic system and endothelial function in cyclosporine-treated kidney allograft recipients.
    Malyszko J; Malyszko JS; Pawlak K; Mysliwiec M
    Transplantation; 1996 Sep; 62(6):828-30. PubMed ID: 8824484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasminogen activators (t-PA and u-PA) and plasminogen activators inhibitors (PAI-1 and PAI-2) in some myeloproliferative syndromes.
    Rość D; Kremplewska-Nalezyta E; Gadomska G; Zastawna E; Michalski A; Drewniak W
    Med Sci Monit; 2000; 6(4):684-91. PubMed ID: 11208392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology.
    Gris JC; Neveu S; Mares P; Biron C; Hedon B; Schved JF
    J Lab Clin Med; 1993 Nov; 122(5):606-15. PubMed ID: 8228580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients.
    van den Dorpel MA; Veld AJ; Levi M; ten Cate JW; Weimar W
    Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1555-8. PubMed ID: 10364089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and prognostic values of plasma levels of fibrinolytic markers in ovarian cancer.
    Ho CH; Yuan CC; Liu SM
    Gynecol Oncol; 1999 Dec; 75(3):397-400. PubMed ID: 10600296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy.
    Coolman M; de Groot CJ; Steegers EA; Geurts-Moespot A; Thomas CM; Steegers-Theunissen RP; Sweep FC
    Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):22-8. PubMed ID: 16584829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of urokinase type plasminogen activator, plasminogen activator inhibitor type 1 and activated protein C in fibrinolysis of human placenta.
    Moniwa N
    Pol J Pharmacol; 1996; 48(2):215-20. PubMed ID: 9112654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placenta and myometrium--the two main sources of fibrinolytic components during pregnancy.
    Uszyński M; Maciejewski K; Uszyński W; Kuczyński J
    Gynecol Obstet Invest; 2001; 52(3):189-93. PubMed ID: 11598362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.
    Urano T; Sakakibara K; Rydzewski A; Urano S; Takada Y; Takada A
    Thromb Haemost; 1990 Feb; 63(1):82-6. PubMed ID: 2111051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of long-term erythropoietin therapy on fibrinolytic system in haemodialyzed patients.
    Pawlak K; Pawlak D; Mysliwiec M
    Thromb Res; 2008; 121(6):787-91. PubMed ID: 17869326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of plasminogen activator inhibitor-1 by angiotensin II receptor blockers on cyclosporine-treated renal allograft recipients.
    Ishikawa A; Ohta N; Ozono S; Kawabe K; Kitamura T
    Transplant Proc; 2005 Mar; 37(2):994-6. PubMed ID: 15848601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between uremic toxin-anthranilic acid and fibrinolytic system activity in predialysis patients at different stages of chronic kidney disease.
    Kaminski TW; Pawlak K; Karbowska M; Mysliwiec M; Grzegorzewski W; Kuna J; Pawlak D
    Int Urol Nephrol; 2018 Jan; 50(1):127-135. PubMed ID: 29058166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulators of fibrynolysis in plasma of kidney transplant recipients.
    Perkowska A; Elhasade A; Gaciong Z; Durlik M; Placha G; Galazka Z; Lao M
    Transplant Proc; 2002 Mar; 34(2):585-8. PubMed ID: 12009632
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperfibrinolysis, uPA/suPAR system, kynurenines, and the prevalence of cardiovascular disease in patients with chronic renal failure on conservative treatment.
    Pawlak K; Buraczewska-Buczko A; Mysliwiec M; Pawlak D
    Am J Med Sci; 2010 Jan; 339(1):5-9. PubMed ID: 19926968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated plasminogen activator inhibitor levels in cyclosporin-treated renal allograft recipients.
    Verpooten GA; Cools FJ; Van der Planken MG; Bedert LC; Claes R; Van Gaal LF; De Broe ME
    Nephrol Dial Transplant; 1996 Feb; 11(2):347-51. PubMed ID: 8671791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.